One Health, "Disease X" & the challenge of "Unknown" Unknowns.

One Health COVID-19 emerging infectious diseases pandemics pathogen pyramid surveillance

Journal

The Indian journal of medical research
ISSN: 0971-5916
Titre abrégé: Indian J Med Res
Pays: India
ID NLM: 0374701

Informations de publication

Date de publication:
03 2021
Historique:
entrez: 28 4 2021
pubmed: 29 4 2021
medline: 1 5 2021
Statut: ppublish

Résumé

The emergence of SARS-CoV-2 and its rapid spread globally emphasizes the ever-present threat of emerging and re-emerging infectious diseases. In this review, the pathogen pyramid framework was utilized to identify the "unknown unknowns" associated with the emergence and rapid transmission of novel infectious disease agents. Given that the evolutionary origin of most of the emerging infectious disease agents can be traced to an animal source, we argue the need to integrate the "One Health" approach as a part of surveillance activities. The need for focusing on undertaking global and regional mapping activities to identify novel pathogens is discussed, given that there are an estimated 1.67 million unknown viruses, of which around 631,000 to 827,000 unknown viruses have the capacity to infect human beings. The emerging risks due to the ever-expanding interface between human, animals, both domestic and wildlife, and the environment are highlighted, these are largely driven by the need for safe habitation, growing food, developing infrastructure to support the increasing human population and desire for economic growth. The One Health approach provides a holistic way to address these cross-sectoral issues, by bridging institutional gaps, enumerating priority risk areas and pathogens, and highlighting putative risk factors for subsequent spillover events involving emerging and re-emerging infectious disease pathogens at the human-animal-environment interface.

Identifiants

pubmed: 33906988
pii: IndianJMedRes_2021_153_3_264_314497
doi: 10.4103/ijmr.IJMR_601_21
pmc: PMC8204831
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

264-271

Déclaration de conflit d'intérêts

None

Références

Nature. 2008 Feb 21;451(7181):898-9
pubmed: 18288175
Science. 2020 Aug 14;369(6505):749
pubmed: 32792371
Infect Ecol Epidemiol. 2016 Nov 29;6:33842
pubmed: 27906123
Health Promot Int. 2020 Apr 1;35(2):181-186
pubmed: 32297931
BMJ. 2021 Feb 1;372:n292
pubmed: 33526414
Lancet Infect Dis. 2020 May;20(5):e108-e115
pubmed: 32197097
Nature. 2007 May 17;447(7142):279-83
pubmed: 17507975
N Engl J Med. 2003 May 15;348(20):1977-85
pubmed: 12671062
Science. 2000 Apr 14;288(5464):287-93
pubmed: 10777411
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
N Engl J Med. 2015 Apr 9;372(15):1381-4
pubmed: 25853741
Nature. 2008 Feb 21;451(7181):990-3
pubmed: 18288193
Epidemiol Health. 2020;42:e2020007
pubmed: 32035431
Philos Trans R Soc Lond B Biol Sci. 2012 Oct 19;367(1604):2864-71
pubmed: 22966141
One Health. 2019 Apr 16;7:100093
pubmed: 31049389
Lancet Glob Health. 2020 Oct;8(10):e1264-e1272
pubmed: 32687792
Nature. 2004 Jul 8;430(6996):242-9
pubmed: 15241422
PLoS Negl Trop Dis. 2016 Sep 02;10(9):e0004957
pubmed: 27588425
Nature. 2017 Jun 29;546(7660):646-650
pubmed: 28636590
Nature. 1969 Feb 1;221(5179):421-5
pubmed: 5784418
Lancet Digit Health. 2020 Apr;2(4):e166-e167
pubmed: 32289116
J Virol. 2015 Oct;89(20):10286-93
pubmed: 26223637
BMC Med Genomics. 2014;7 Suppl 3:S1
pubmed: 25521718
Vet J. 2018 Apr;234:43-47
pubmed: 29680392
Nat Med. 2020 Apr;26(4):450-452
pubmed: 32284615
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
BMJ. 2020 Dec 15;371:m4735
pubmed: 33323384
Emerg Microbes Infect. 2018 Sep 12;7(1):154
pubmed: 30209269
Trop Doct. 2020 Apr;50(2):166-169
pubmed: 31771428
Epidemiol Health. 2020;42:e2020006
pubmed: 32023775
BMJ. 2020 Dec 15;371:m4750
pubmed: 33323376
N Engl J Med. 2020 Apr 30;382(18):1677-1679
pubmed: 32109012
Emerg Infect Dis. 2005 Dec;11(12):1822-7
pubmed: 16485465
Indian J Med Res. 2020 Feb & Mar;151(2 & 3):147-159
pubmed: 32362642
Science. 2018 Feb 23;359(6378):872-874
pubmed: 29472471
Int J Infect Dis. 2016 Apr;45:1-4
pubmed: 26875601
Lancet Glob Health. 2020 Sep;8(9):e1132-e1141
pubmed: 32673577
J Indian Med Assoc. 2008 Oct;106(10):660-3
pubmed: 19552100
Lancet. 2003 Oct 25;362(9393):1353-8
pubmed: 14585636
mSphere. 2016 Apr 06;1(2):
pubmed: 27303732
Microbiol Spectr. 2013 Oct;1(1):
pubmed: 26184815
Proc Natl Acad Sci U S A. 2013 May 21;110(21):8399-404
pubmed: 23671097
mBio. 2013 Sep 03;4(5):e00598-13
pubmed: 24003179
Infect Dis Poverty. 2016 Oct 3;5(1):87
pubmed: 27716352
Nature. 1999 Feb 4;397(6718):436-41
pubmed: 9989410
PLoS One. 2017 May 2;12(5):e0175745
pubmed: 28463989
Lancet Glob Health. 2020 Jul;8(7):e901-e908
pubmed: 32405459
Int J Infect Dis. 2007 Jan;11(1):29-35
pubmed: 16678463
AIDS. 1989 Oct;3(10):625-30
pubmed: 2512955
Lancet Glob Health. 2019 Oct;7(10):e1314-e1316
pubmed: 31537354
FEMS Microbiol Lett. 2018 Jun 1;365(11):
pubmed: 29790983
Trop Med Infect Dis. 2019 May 31;4(2):
pubmed: 31159338
Front Public Health. 2015 Oct 12;3:219
pubmed: 26528460
PLoS One. 2015 Jun 19;10(6):e0129827
pubmed: 26090682
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Lancet. 2020 Mar 14;395(10227):850-852
pubmed: 32135077

Auteurs

Pranab Chatterjee (P)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.

Parvati Nair (P)

Médecins Sans Frontières, The Netherlands.

Matthew Chersich (M)

Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, South Africa.

Yitagele Terefe (Y)

Tropical Animal Health and Control of Zoonoses, College of Veterinary Medicine, Haramaya University, Ethiopia.

Abhimanyu Singh Chauhan (AS)

Public Health Consultant, Eindhoven, The Netherlands.

Fabiola Quesada (F)

Wildlife Conservation Medicine Foundation, Spain.

Greg Simpson (G)

Wildlife Forensic Academy, Cape Town, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH